Simian virus 40 may be associated with developing malignant pleural mesothelioma

Thanh,Tran  Dinh; Tho,Nguyen  Van; Lam,Nguyen  Son; Dung,Nguyen  Huy; Tabata,Chiharu; Nakano,Yasutaka

doi:10.3892/ol.2016.4174

Simian virus 40 may be associated with developing malignant pleural mesothelioma

Authors:
- Tran Dinh Thanh
- Nguyen Van Tho
- Nguyen Son Lam
- Nguyen Huy Dung
- Chiharu Tabata
- Yasutaka Nakano
View Affiliations

Affiliations: Department of Oncology, Pham Ngoc Thach Hospital, Ho Chi Minh City 00848, Vietnam, Department of Tuberculosis and Lung Diseases, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam, Cancer Center, Hyogo College of Medicine, Nishinomiya, Hyogo 663‑8501, Japan, Division of Respiratory Medicine, Department of Medicine, Shiga University of Medical Science, Otsu, Shiga 520‑2192, Japan
Published online on: February 1, 2016 https://doi.org/10.3892/ol.2016.4174
Pages: 2051-2056
Copyright: © Thanh et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant pleural mesothelioma (MPM) is associated with a history of heavy, long-term exposure to asbestos. However, MPM may also be associated with simian virus 40 (SV40), a polyomavirus. The association between SV40 and MPM remains unclear. The present study was conducted in order to investigate the proportion of SV40 presence in the histological specimens of Vietnamese patients with MPM. Histological specimens were obtained from 45 patients (19 men and 26 women) with MPM at the Pham Ngoc Thach Hospital in Ho Chi Minh City, Vietnam. The specimens were processed and examined in order to detect the presence of the SV40 large T antigen (SV40 Tag) expression using immunohistochemistry. Of the 45 patients, 23 (51%) were epithelioid, 7 (16%) were biphasic, 6 (13%) were sarcomatoid, 4 (9%) were desmoplastic, 4 (9%) were well‑differentiated papillary and 1 (2%) was the anaplastic subtype. In total, 9/45 patients (20%) demonstrated SV40 Tag expression. The proportion of patients that demonstrated SV40 Tag expression was not significantly different between the epithelioid subtype and the other subtypes (22 vs. 18%; P=1.000) or between the patients with stage IV disease and other stages (20 vs. 20%; P=1.000). The median survival time was not significantly different between the patients with or without SV40 Tag expression (196 vs. 236 days, P=0.8949). In summary, a 5th of the Vietnamese patients with MPM were associated with infection with SV40. SV40 may be a potential cause of MPM in Vietnam and this potential association requires additional studies.

View Figures

View References

1	Robinson BM: Malignant pleural mesothelioma: An epidemiological perspective. Ann Cardiothorac Surg. 1:491–496. 2012.PubMed/NCBI
2	Robinson BW, Musk AW and Lake RA: Malignant mesothelioma. Lancet. 366:397–408. 2005. View Article : Google Scholar : PubMed/NCBI
3	Cugell DW and Kamp DW: Asbestos and the pleura: A review. Chest. 125:1103–1117. 2004. View Article : Google Scholar : PubMed/NCBI
4	Yang H, Testa JR and Carbone M: Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol. 9:147–157. 2008. View Article : Google Scholar : PubMed/NCBI
5	Carbone M, Pannuti A, Zhang L, Testa JR and Bocchetta M: A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res. 68:9488–9496. 2008. View Article : Google Scholar : PubMed/NCBI
6	Carbone M, Pass HI, Miele L and Bocchetta M: Novel developments about the association of SV40 with human mesothelioma. Oncogene. 22:5173–5180. 2003. View Article : Google Scholar : PubMed/NCBI
7	Jaurand MC and Fleury-Feith J: Pathogenesis of malignant pleural mesothelioma. Respirology. 10:2–8. 2005. View Article : Google Scholar : PubMed/NCBI
8	Comar M, Rizzardi C, de Zotti R, Melato M, Bovenzi M, Butel JS and Campello C: SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res. 67:8456–8459. 2007. View Article : Google Scholar : PubMed/NCBI
9	Jin M, Sawa H, Suzuki T, Shimizu K, Makino Y, Tanaka S, Nojima T, Fujioka Y, Asamoto M, Suko N, et al: Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan. J Med Virol. 74:668–676. 2004. View Article : Google Scholar : PubMed/NCBI
10	Testa JR, Carbone M, Hirvonen A, Khalili K, Krynska B, Linnainmaa K, Pooley FD, Rizzo P, Rusch V and Xiao GH: A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res. 58:4505–4509. 1998.PubMed/NCBI
11	Aoe K, Hiraki A, Murakami T, Toyooka S, Shivapurkar N, Gazdar AF, Sueoka N, Taguchi K, Kamei T, Takeyama H, et al: Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Sci. 97:292–295. 2006. View Article : Google Scholar : PubMed/NCBI
12	Hirvonen A, Mattson K, Karjalainen A, Ollikainen T, Tammilehto L, Hovi T, Vainio H, Pass HI, Di Resta I, Carbone M and Linnainmaa K: Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog. 26:93–99. 1999. View Article : Google Scholar : PubMed/NCBI
13	López-Ríos F, Illei PB, Rusch V and Ladanyi M: Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet. 364:1157–1166. 2004. View Article : Google Scholar : PubMed/NCBI
14	Pilatte Y, Vivo C, Renier A, Kheuang L, Greffard A and Jaurand MC: Absence of SV40 large T-antigen expression in human mesothelioma cell lines. Am J Respir Cell Mol Biol. 23:788–793. 2000. View Article : Google Scholar : PubMed/NCBI
15	De Rienzo A, Tor M, Sterman DH, Aksoy F, Albelda SM and Testa JR: Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem. 84:455–459. 2002. View Article : Google Scholar : PubMed/NCBI
16	Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A and Inai K: Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int. 57:190–199. 2007. View Article : Google Scholar : PubMed/NCBI
17	Sandeck HP, Røe OD, Kjærheim K, Willén H and Larsson E: Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry. Diagn Patho. 5:472010. View Article : Google Scholar
18	Allred DC, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155–168. 1998.PubMed/NCBI
19	Nguyen GK and Kline TS: Cytology laboratory and quality assurance practice. Essentials of Exfoliative Cytology (New York, NY). Igaku-Shoin Medical Publishers, Inc. 6–13. 1992.
20	De Vuyst P, Dumortier P, Moulin E, Yourassowsky N, Roomans P, de Francquen P and Yernault JC: Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration. Eur Respir J. 1:362–367. 1988.PubMed/NCBI
21	Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P and Carbone M: Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res. 65:10273–10279. 2005. View Article : Google Scholar : PubMed/NCBI
22	Martini F, Corallini A, Balatti V, Sabbioni S, Pancaldi C and Tognon M: Simian virus 40 in humans. Infect Agent Cancer. 2:132007. View Article : Google Scholar : PubMed/NCBI
23	Xaubet A, Rodriguez-Roisín R, Bombí JA, Marín A, Roca J and Agustí-Vidal A: Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis. 133:848–854. 1986.PubMed/NCBI
24	Kroczynska B, Cutrone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, Mossman BT, Pass HI and Carbone M: Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci USA. 103:14128–14133. 2006. View Article : Google Scholar : PubMed/NCBI
25	Cicala C, Pompetti F and Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol. 142:1524–1533. 1993.PubMed/NCBI
26	Milano MT and Zhang H: Malignant pleural mesothelioma: A population-based study of survival. J Thorac Oncol. 5:1841–1848. 2010. View Article : Google Scholar : PubMed/NCBI
27	van der Bij S, Koffijberg H, Burgers JA, Baas P, van de Vijver MJ, de Mol BA and Moons KG: Prognosis and prognostic factors of patients with mesothelioma: A population-based study. Br J Cancer. 107:161–164. 2012. View Article : Google Scholar : PubMed/NCBI